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The development of agricultural biotechnology humanitarian projects for food security in the last five years has
been rapid in developing countries and is expected to rise sharply over the coming years. An extremely critical issue
in these projects involves building trust with the community and farmers they aim to serve. For the first time, our
social audit engagement with one of these initiatives, the Water Efficient Maize for Africa project, has revealed that
a critical but unrecognized component of building trust with farmers involves publicly addressing the concerns
surrounding stacked trait crops. As a result, we argue in this article that it is critical to actively anticipate the
concerns that could be raised over trait stacking by incorporating them into global access plans of such initiatives
early in order to facilitate adoption, provide the best value to the small-scale farmer and gain trust with the
community whom these projects aim to serve. This perspective, based on an actual international social audit,
should be of value to scientists, funders and partners involved in biotech development initiatives for food security.
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Publicly addressing the concerns over stacked trait crops
early on in biotech development initiatives provides great
potential to generate mutually advantageous solutions
for all partners and stakeholders, enhance opportunities
to build trust, and increase the likelihood that the initia-
tive will succeed. We make this proposition based on
our experience with the Water Efficient Maize for Africa
(WEMA) project, which is a public-private partnership
(PPP) working to develop drought-tolerant, royalty-free
African maize varieties for small-scale farmers in sub-
Saharan Africa using a combination of conventional and
marker-assisted breeding and transgenic technology.
The term ‘trait stacking’ for genetically modified (GM)
or biotech crops refers to the incorporation of multiple
genetic modifications, or traits, in a single variety of a crop
[1]. Crops with stacked traits are more effective at meeting
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reproduction in any medium, provided the origmono-trait seed varieties because they allow for a product
to be modified for multiple traits concurrently such as tol-
erance to herbicides, resistance to insects and improved
nutritional content [2].
The first stacked crop to be fully commercialized was a
cotton seed that was produced using patented genes owned
and developed by Monsanto, a multinational agricultural
biotechnology company. These incorporated genes provide
protection against certain pests and enable the use of the
herbicide glyphosate [1]. The case of this cotton seed has
been followed by the commercialization of other crops with
stacked traits such as the AgrisureW 3000GT which protects
against corn borer and corn rootworm while providing tol-
erance to in-season applications of certain herbicides [3]. A
total of 42.2 million hectares of stacked biotech crops were
planted in 2011, compared to 32.2 million hectares in 2010.
The WEMA project engages a number of stakeholders
from both the public and private sector, including the
African Agricultural Technology Foundation (AATF);
the International Maize and Wheat Improvement Center
(CIMMYT); the Monsanto company; and five National
Agricultural Research Systems (NARS) in Kenya,
Tanzania, South Africa, Uganda and Mozambique [4]. InLtd. This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
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conducted a social audit of the WEMA project, which is
funded by the Bill & Melinda Gates Foundation [5]. A
social audit is a process whereby an audit team collects
and analyses information from stakeholders in order to
produce an account of a project’s ethical, social and cul-
tural performance and impact.
The findings of the social audit revealed that, despite
the many examples of stacked trait crops being commer-
cialized, they are not regularly considered in agbiotech
projects for humanitarian purposes. Based on the
unique findings from our audit, we posit that agricul-
tural development projects must anticipate the concerns
that could be raised over trait stacking and incorporate
them into their project plans early in order to build trust
with stakeholders.
Addressing trait stacking early builds trust
The goal of the social audit was to discover and address
barriers to building trust in agricultural development
initiatives, such as the WEMA project, as a means to en-
sure the best project outcomes for the small-scale farmer.
Public-private partnerships involved in agbiotech projects
face issues of public distrust due to concerns surrounding
the use of transgenic technology and the complex nature
of these partnerships, which comprise organizations with
varied interests and priorities. As such, PPPs engaged in
agbiotech projects may sometimes face public scrutiny or
experience a lack of trust due to diverse points of view,
such as those contextualized by ethical, social, cultural or
commercialization concerns [6].
This lack of trust poses a significant risk to the hu-
manitarian goals of such projects. This risk could be exa-
cerbated if important issues relevant to building trust
among project partners and the public are not appropri-
ately addressed at an early stage in project development.
A barrier to establishing trust, as identified by project
stakeholders in the social audit of the WEMA project,
was the issue of trait stacking [2]. These stakeholders
comprise of farmers, managers of seed companies, bio-
safety regulators, scientists, legal consultants and other
experts in the agricultural development sector. They
noted that that publicly and transparently addressing
concerns around stacked traits is necessary and pro-
ductive when developing agbiotech projects. This
would mitigate various concerns that stakeholders
have, such as worry that the project could be a poten-
tial ploy for private companies to gain access to the
African market. Environmental groups such as Green-
peace have dubbed such projects ‘Trojan horses’, assert-
ing that these projects are merely another means for
large biotech companies to extend their GM market
base especially as technology allows for further trait
stacking [7].Stacked traits also facilitate adoption of biotech
crops
Although the goal of creating the WEMA variety is to
provide a low-cost, royalty-free variety of drought-tolerant
maize to small-scale farmers, our social audit panelists
have indicated that it will be difficult to ensure adoption
without other critical traits.
Stacked traits are becoming an increasingly important
feature of biotech crops, and farmers are beginning to
recognize the benefits of including stacked crops in their
farming practices [2]. In 2011, biotech crops were
planted by twelve countries, nine of which were develop-
ing countries. In the same year, stacked double- and
triple-traits occupied 26% of the global biotech land area
[8]. These events suggest that drought-tolerant seeds that
are not stacked with important traits are unlikely to be
adopted, especially if other seeds with these significant
characteristics are available.
Stacked crops represent important upcoming technolo-
gies for farmers. In general, when the needs of farmers
are considered in the development of crops, the likelihood
of them adopting such crops is greater. This is reflected
by the increased rate of adoption of crops with stacked
traits over the last few years [2].
Overcoming constraints: cost and multiple-partner
engagement
If publicly addressing concerns about stacked traits in
humanitarian projects is valuable in building public trust
and eventually facilitating adoption, it is surprising that
the use of stacked traits has yet to be considered and
publicly addressed in the early stages of these projects.
We believe that this is due to two challenges: concern
with cost-effectiveness and enabling multi-partner en-
gagement. These constraints can be easily overcome,
however. For example, one of the projects under the
Grand Challenges in Global Health of the Gates Founda-
tion is the Golden Rice project, which is designed to en-
gineer rice for increased levels of beta carotene (vitamin
A precursor), vitamin E, and enhanced iron (Fe) and zinc
(Zn) bioavailability [9]. The engineered rice, targeted to
the poor in developing countries, is perhaps one of the
most well-known GM varieties in development, and has
been successful in overcoming the challenge of maintain-
ing cost-effectiveness through the use of a humanitarian-
defined license [10]. The project negotiated access to all
necessary patents from companies including Bayer AG,
Monsanto, Novartis AG, Orynova BV, and Zeneca Mogen
BV - all of whom agreed to provide access to their tech-
nologies free of charge for a defined humanitarian pur-
pose, making end-user licensing relatively uncomplicated
[11,12].
In addition to the issue of cost-effectiveness is the chal-
lenge of engaging multiple seed companies, as individual
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need to be incorporated into a single product. However,
the complexities of multi-stakeholder involvement are not
unprecedented when it comes to agbiotech initiatives.
Maize with stacked traits acquired from multiple compan-
ies has been successfully developed and implemented in
the past. For example, in 2007, AgrisureW 3000GT, a
triple-stack maize hybrid that protects against both corn
borer and corn rootworm, was developed. It includes
traits that are owned by different companies and is mar-
keted by Syngenta through a licensing agreement with
Monsanto [1,13]. Additionally, both companies have
granted external companies [including competitors] stack-
ing rights to their traits. Although admittedly complex,
the AgrisureW 3000GT is an example that highlights the
ability of industry competitors to effectively incorporate
their respective biotechnologies into a single end product.Conclusions
The concerns raised over the use of stacked traits as
uniquely revealed by our social audit of the WEMA pro-
ject are applicable to other current and upcoming agbio-
tech projects. Principal investigators and funders of
humanitarian agbiotech initiatives should actively antici-
pate these concerns and incorporate them into their pro-
ject plans in order to gain trust with the community they
aim to serve. Although issues such as cost-effectiveness
and the engagement of multiple project partners may be
perceived as constraints to incorporating the use of
stacked traits in agbiotech development projects, cases
such as the Golden Rice project and AgrisureW 3000GT
demonstrate that such obstacles can be overcome, espe-
cially if project partners commit to maintaining a hu-
manitarian focus. We believe that publicly addressing
concerns surrounding stacked traits early in biotech de-
velopment initiatives will increase the potential of all
partners and stakeholders to generate mutually advanta-
geous solutions and enhance opportunities to build trust.
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